FDA STAFF MANUAL GUIDES, VOLUME II - DELEGATIONS OF AUTHORITY
ADMINISTRATIVE – FINANCIAL MANAGEMENT
AUTHORITY TO COMPROMISE, TERMINATE, OR SUSPEND COLLECTION OF CLAIMS UNDER THE FEDERAL CLAIMS COLLECTIONS ACT
Effective Date: 01/08/2010
1. AUTHORITY DELEGATED.
To compromise or terminate debts or to suspend collection of claims of $100,000 or less, exclusive of interest, under the Federal Claims Collection Act, as amended (31 U.S.C. 3711), insofar as such authority relates to the activities of the Food and Drug Administration.
For claims greater than $100,000, the authority to compromise, terminate or suspend claims rests with the Department of Justice.
2. TO WHOM DELEGATED.
A. Director, Office of Financial Management (OFM), Office of Financial Operations (OFO).
B. Director, Division of Accounting, OFM, OFO.
All previous delegations of authority inconsistent with the provisions of this delegation are superseded.
Prior to termination of claims, FDA and FDA’s debt collection agency (PSC) will exhaust all avenues of collection including the Department of Justice and Department of Treasury Off-set Programs.
4. REDELEGATION AND CERTIFICATION.
These authorities may not be further redelegated.
5. EFFECTIVE DATE.
Russell J. Abbott, Deputy Commissioner for Administration, approved this delegation, via memorandum, on January 8, 2010.
|STATUS (I, R, C)||DATE APPROVED||LOCATION OF CHANGE HISTORY||CONTACT||APPROVING OFFICIAL|
|Initial||09/16/2008||N/a||OC/OM/OMP||John P. Gentile, Associate Commissioner for Operations|
|Revised||01/08/2010||N/a||OC/OA/OFO||R. Abbott, Deputy Commissioner for Administration|